CLB
Core Laboratories NV
10.40$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 63.8% | 70.2% | 78.9% | 75.7% | 74.2% | 74.2% | 79.0% | 82.2% | 83.9% | 81.6% | 83.1% | 82.1% | |
| 36.2% | 29.8% | 21.1% | 24.3% | 25.8% | 25.8% | 21.0% | 17.8% | 16.1% | 18.4% | 16.9% | 17.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 4.2% | 6.2% | 6.6% | 7.2% | 9.0% | 7.2% | 7.0% | 9.4% | 7.8% | 7.9% | 7.4% | 8.4% | |
| 4.2% | 6.2% | 6.6% | 7.2% | 9.0% | 11.4% | 36.7% | 8.2% | 7.6% | 7.7% | 5.7% | 8.3% | |
| 31.9% | 20.2% | 14.5% | 17.0% | 16.9% | 14.5% | -15.8% | 9.6% | 8.5% | 10.7% | 11.2% | 9.6% | |
| 1.0% | 1.6% | 1.9% | 1.6% | 1.9% | 2.2% | 2.9% | 1.9% | 2.4% | 2.6% | 2.4% | 2.0% | |
| 31.0% | 18.6% | 12.5% | 15.4% | 15.0% | 12.3% | -18.7% | 7.7% | 6.1% | 8.1% | 8.8% | 8.7% | |
| 7.1% | 4.2% | 1.8% | 2.8% | 3.6% | -1.8% | 1.2% | 3.4% | 2.1% | 0.8% | 2.7% | 2.9% | |
| 23.7% | 14.4% | 10.7% | 12.6% | 11.3% | 15.3% | -20.0% | 4.2% | 4.0% | 7.2% | 6.0% | 5.6% | |
| 34.4% | 23.6% | 19.0% | 20.4% | 20.2% | 18.7% | 14.5% | 13.6% | 12.0% | 13.8% | 14.0% | 13.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.